CellBank Australia has released two cell lines for the study of chromatin architecture and dynamics. The HeLa derivatives are genetically modified to carry fluorescently tagged histone H2B proteins.
The Applied Biosystems TaqCheck SARS-CoV-2 Fast PCR Assay uses raw saliva samples and is designed to simplify lab workflows using instruments that are widely available to deliver data quickly.
BioAuxilium has developed its line of high-quality, fully validated Thunder cell signalling assays based on time-resolved Förster resonance energy transfer (TR-FRET) technology.
Tecan has launched the Crescendo cDNA Synthesis for qPCR system to provide increased sensitivity for low-input applications. It uses Tecan's Single Primer Isothermal Amplification (SPIA) technology to generate large quantities of cDNA from as little as 500 pg of total RNA.
StarBright Blue 700, StarBright Violet 440 and StarBright Violet 610 are fluorescent nanoparticles that are conjugated to Bio-Rad's highly validated flow antibodies, providing high brightness and resolution.
The LUNA-FX7 is claimed to provide unmatched cell counting accuracy, dual fluorescent and brightfield detection, advanced de-clustering algorithm, precision autofocus and 21 CFR PART 11 compliance.
The rollout of new, World Health Organization-approved, antigen-based rapid diagnostic tests for COVID-19 in Africa is expected to significantly boost testing capacity.
Cayman Chemical's ferroptosis suppressor protein 1 (FSP1) and glutathione peroxidase 4 (GPX4) inhibitor screening kits provide a robust and easy-to-use platform for identifying novel inhibitors of human FSP1 and GPX4, which are negative regulators of the ferroptosis pathway.
The Xfree COVID-19 Direct RT-PCR test is a complete test in a single vial, lyophilised in the BioGX Sample-Ready format. Just add water and the patient sample, and run the test on a validated real-time PCR instrument.
Bio-Rad Laboratories' CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems are suitable for research and genomic testing as well as in pathogen detection and infectious disease testing.
PixCell Medical has received regulatory approval from the Therapeutic Goods Administration (TGA) for its HemoScreen device, designed to make the most common complete blood count (CBC) test accessible locally when results are needed quickly.
The kit contains all the components necessary for sensitive quantification of DNA libraries prior to next-generation sequencing (NGS) with Illumina platforms.